Risk Factors for Oral Cancer Development in British Columbia: Lessons Learned from History CONCLUSIONS  This is the first step to examine this unique,

Slides:



Advertisements
Similar presentations
Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
Advertisements

Northern Arizona University Dental Hygiene
Prevention and Early Detection of Oral Cancer For The Public Presented at the quarterly meeting of The Essex County Cancer Coalition March 29, 2012 UMDNJ.
Professor Department of Biomedical Informatics University of Pittsburgh School of Medicine Rebecca Crowley Jacobson.
4.6 Assessment of Evaluation and Treatment 2013 Analytic Lung Cancer.
Module 3 Clinical Manifestations. Introduction  Intraoral cancers occur most frequently on the: ­Tongue ­Floor of the mouth ­Soft palate and ­Oropharynx.
M DesMeules, J Gold, B Vissandjée, D Manuel, A Kazanjian, J Payne, Y Mao Health Canada, Ottawa; University of Montreal, Montreal; Institute for Evaluative.
ENHANCING DETECTION.... YOUR PRACTICE.
Periodontal Disease Risk Developed by PreViser, Inc. Courtesy PreViser Corporation, all rights reserved.
1 Detecting Oral Cancer A guide for health care professionals U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute.
Mauricio A. Moreno, M.D. Assistant Professor Department of Otolaryngology- Head and Neck Surgery University or Arkansas for Medical Sciences Mauricio A.
1 Canadian Institute for Health Information. Hospital Care for Heart Attacks Among First Nations, Inuit and Métis Released January 31,
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Population-based Study Of Giant Cell Tumour Of The Bone In Sweden Justyna Amelio, 1 Julia Sandberg, 2 Rohini K. Hernandez, 3 Patrik Sobocki, 4 Scott Stryker,
Cancer: The Clinical and Diagnostic Approach
 Most people have heard of cancer affecting parts of the body such as lungs or breasts however,cancer can occur in the mouth, where the disease can effect.
Oral Cavity Pathology Last Updated: Oct. 3, 2006.
Breast Cancer Risk Factors
D etection of E arly Lung C ancer A mong M ilitary P ersonnel Study 1 Version
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Fluorescent In Situ Hybridization (FISH) to Identify Genetic Changes in Fine Needle Biopsy of Lung Lesions Prepared by Jin Jen NCI.
The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
1 Detecting Oral Cancer A guide for health care professionals.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
The Inflammatory Breast Cancer Cancer Registry Paul H. Levine, M.D. Paul H. Levine, M.D. The George Washington University School of Public Health and Health.
Upon completion of this lesson, you will be able to: Identify different diagnostic procedures for breast cancer screening Describe different diagnostic.
This material is protected by United States copyright law, and includes content owned by Discovery Education, The Val Skinner Foundation, and Rutgers,
Dr. Rupak Sethuraman. SPECIFIC LEARNING OBJECTIVES To learn the common white lesions of the oral mucosa. To learn the etiopathogenesis, clinical features,
Squamous Cell Carcinoma DH 125 Head and Neck Anatomy, Histology, and Embryology 12/9/15 Neda Sarlak #15 Susana Orlando #3 Wendy Moy #11 Samantha Strong.
BC Cancer Agency CARE & RESEARCH Breast Cancer Mortality After Screening Mammography in British Columbia Women Andrew J. Coldman, Ph.D. Norm Phillips,
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
SKIN CANCER PREVENTION May Skin Cancer in Saskatchewan & Canada PART TWO.
SaliMark™ OSCC Investigator Meeting Salivary Transcriptome Markers for Oral Squamous Cell Carcinoma Detection SaliMark™ OSCC.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
From Qualitative to Quality Impact Heather Bryant, MD, PhD Health System Use Summit February, 2016.
Cancer in Ontario: Overview A Statistical Report.
Linking Electronic Health Records Across Institutions to Understand Why Women Seek Care at Multiple Sites for Breast Cancer Caroline A. Thompson, PhD,
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparison of MR/Ultrasound Fusion–Guided Biopsy With.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
Collection of Cervical Carcinoma In Situ in Michigan NAACCR Conference San Diego – 2009 Glenn Copeland, Michigan Cancer Surveillance Program Meg Watson,
Biomedical Research Centre for Mental Health and Dementia Unit at South London and Maudsley NHS Foundation Trust the Institute of Psychiatry, King’s College.
Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,
Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.
Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.
DR MOHAMMED MALIK AFROZ ORAL CANCER – ETIOLOGY AND CLINICAL FEATURES.
SHOULD I BIOPSY THIS? SHOULD I BIOPSY THIS? TANYA A. WRIGHT, DDS.
Cancer prevention and early detection
Developing a Curriculum Emphasizing Oral medical examination for improvement of patient care in a diverse population Ezinne Ogbureke, BDS,DMD ; Ana Neumann.
Evie Landry, Kimberly Luu, Jane Lea, Brian Westerberg
Compassionate People World Class Care
Prevention and Early Detection of Oral Cancer For The Public
Cancer in Wales Population incidence of stage at diagnosis Official statistics Published 09:30 hrs 24 November
EVALUATING THE EARLY EFFECTS OF TRU-CUT BIOPSY UNDER CT GUIDANCE IN PATIENTS WITH LUNG TUMOUR AT NATIONAL LUNG HOSPITAL. Dr. Phuong Ngoc Anh National Lung.
National Cancer Statistics in Korea, 2015
Expression of apocrine markers at various stages of apocrine carcinoma progression. Expression of apocrine markers at various stages of apocrine carcinoma.
Timely Access to Health Care Minister George Abbott Ministry of Health Government of British Columbia.
Cervical Cancer Surveillance, Screening, and Treatment
A, unsupervised hierarchical clustering of the expression of probe sets differentially expressed in the oral mucosa of smokers versus never smokers. A,
A and B, images from a patient with an invasive carcinoma on the floor of the mouth. A and B, images from a patient with an invasive carcinoma on the floor.
Fig. 5 Proportions of EpCAM+ systemic tumor cells correlate with the clinical outcome of patients with MBC. Proportions of EpCAM+ systemic tumor cells.
Presentation transcript:

Risk Factors for Oral Cancer Development in British Columbia: Lessons Learned from History CONCLUSIONS  This is the first step to examine this unique, 30-year population-based material.  With the analysis of this enriched archive materials (patient and lesion information and archive paraffin tissue), we will be able to better understand the nature history of disease. Anna Chen 1 *, Keith Hau 1, Jennifer Ryu 1, Lewei Zhang 1, Catherine F. Poh 1,2 1 The University of British Columbia, Vancouver, Canada; 2 BC Cancer Agency, Vancouver, BC, Canada Research supported by grants CCSRI from the Canadian Cancer Society Research Institute; Canadian Institute for Health Research and Michael Smith Foundation OBJECTIVES 1)to retrieve comprehensive clinical and pathological information from of all oral mucosal biopsies. 2)to link the outcome data [Pathology database (1995 to 2010) and BC Cancer Registry Data (1995 to 2010)]. INTRODUCTION  The establishment of a risk predictive model can have important public health implications.  Health professionals have used reliable risk prediction tools for breast and lung cancers. ( Bach et al., 2003; Gail et al., 2009)  There is a lack of such model in oral cancer prediction.  In BC, we have a unique provincial Oral Biopsy Service (OBS) providing pathology diagnostic service for the dental network since  This service provides us an unique opportunity to retrieve key attributes from a population- based network and enables us to build an oral cancer risk model. BC OCPP METHOD  The study is approved by the BCCA/UBC Research Ethic Board (H11-659).  Hard copies of oral mucosal biopsies including the requisition form filled by submitting dentists and the path reports are manually reviewed, retrieved and scanned between 1995 and 1997 and electronic pathology data queried from Pathology database from 1997 to  An excel database was developed with collection of patient’s demographics, lesion characteristics, and diagnosis.  Personal health number was used to identify outcome through the linkage to Pathology database and the BC Cancer Registry.  Among these, 2044 biopsies were identified as white lesions clinically.  Pathology diagnoses of these lesions include hyperplasia (N = 1198, 59%), dysplasia (N = 301, 15%), squamous cell carcinoma (N = 60, 3%), lichen planus or lichenoid mucositis (N=398, 19%), actinic cheilitis (N = 5, 0.24%), and oral candidiasis (N = 82, 4%).  The most common anatomical sites present with white lesions clinically are gingiva (N = 429, 23%), palate (444, 24%), and buccal mucosa (375, 20%). See Figures 2&3.  Squamous cell carcinoma (N= 60) Among 60 patients diagnosed with oral squamous cell carcinoma, they were mainly male (56%), Caucasian (90%), and were ever smoked (53%). The average age was ± 15.81years.The most common sites are the floor of mouth and tongue (N = 28, 46.67%) (Figure 2). Figure 1. Trends in mucosal biopsies, precancerous and cancer biopsies, and registered dentists per 1,000 resident. The blue line shows the incidence of mucosal biopsy has increased ~ 1.23 times (0.34, 1995 vs. 0.41, 1998, per 1,000 persons in BC). The green line shows the increment of the dentists in BC from It is found there is no increase in biopsy number per dentist (0.6 dentists/1000 residents/ year). The red line shows the incidence of precancerous and cancerous lesions has increased ~ 1.39 times (2.14, 1995 vs. 2.92, 1998, per 100,000 persons in BC).  Excluding SCC, there are 1984 white lesions and 15 (0.8%) lesions/cases progress into cancer (Figure 3).  Surprisingly, six of them were not dysplasias.  In the 15 progression cases, they were mainly male (53%), Caucasian (91%), and were ever smoker (71%). The average age was ± years. The most common sites are the floor of mouth and tongue (N = 9, 60%).  The best risk indicator remains the presence of dysplasia (9/301, 3% dysplasia cases progressed). Figure 2. Anatomical site distribution and presence of squamous cell carcinoma (SCC). Left pie chart: showing the proportion of the white lesions among all mucosal biopsies in (Yellow slice represents white lesions among all mucosal biopsies and light blue represents the rest). Right pie chart: showing the anatomical distribution of these clinically white lesions and each white dot represents a progressed biopsy. It is shown to have a higher proportional distribution at the floor of mouth and tongue. Figure 3. Cases of progression in the white lesions and their anatomical distribution. 15 cases out of 1984 white lesions have later progressed into cancer. Progression cases are shown as white triangles. 26% RESULTS  The incidence of mucosal biopsy has increased ~ 1.22 times (0.33,1995 vs. 0.41, 1998, per 1,000 persons in BC).  There is no true increment of the number of biopsies per dentist over years (0.6 dentists/1000 residents/ year).  However, the incidence of precancerous and cancerous lesions has increased ~1.39 times. (Figure 1).  From , 5917 (43%) mucosal biopsies from a total of 13,827 biopsy samples were identified. Anatomical site 4% 6% 4%